2013 Agenda
Oxford Global Conferences is proud to introduce the next event in our life sciences series in Asia – 2nd Annual Clinical Outsourcing Asia Congress 2013, which will be co-located with our 3rd Annual R&D Asia Congress, to be held in Shanghai China on the 17th-18th Jan 2013.
Over the 2 days the congress will cover topic areas on clinical development, outsourcing and clinical trials management. It also looks at key strategies in forging partnerships & strategic alliances for pharma companies, biopharma companies and research institutions in the Asia market. Another key feature of this event is the use of biomarkers in clinical development and adaptive trial design.
The 2013 Agenda at a glance:
Day 1 Stream 1 – Clinical Research & Outsourcing Strategies in Asia
- Selecting the right CRO
- Overcoming contract challenges
- Building long term partnerships and goals – Managing vendor relationships
- Partnership models to maximise CRO performance
- Improve quality and speed of clinical trials
- New trends in global clinical trials and the role in China, India and emerging countries in Europe
- Conducting clinical trials in emerging markets
- Monitoring of clinical trials globally
Day 1 Stream 2 – Clinical Development in Oncology and other Therapeutic Areas in China and other APAC Regions
- Establishing acceptable endpoints
- Developing targeted therapies
- Innovation in clinical imaging
- Co-development of combined therapies
- Avoiding late-stage failures
- Managing safety in early development
Day 2 Stream 1 – Managing Clinical Trial Operations: Patient Recruitment, Retention& Biomarker Trial Design
- Optimizing patient recruitment
- Patient recruitment to sample data analysis
- Patient retention strategies
- Regulatory, policy, technology adoption challenges in Asia
- Country and site selection for global clinical trials and clinical trials management strategies
- Biomarkers for adaptive trial design
- Implementation of oncology biomarker strategies in clinical development
Day 2 Stream 2 – Clinical Trials Management in Oncology and other Therapeutic Areas in China and other APAC Regions
- Managing Trials China and in emerging markets
- Registration, Regulation and compliance
- Alternatives to Global Development in Emerging Markets
- Data Management
